CN Stock MarketDetailed Quotes

300558 Betta Pharmaceuticals

Watchlist
  • 55.22
  • +0.72+1.32%
Market Closed Dec 20 15:00 CST
23.11BMarket Cap50.29P/E (TTM)

Betta Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Betta Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 818.440M--
--2023/Q1-- / 531.619M--
--2024/Q3843.877M / 765.760M--
--2024/Q2764.990M / 770.395M--
--2024/Q1735.775M / 700.292M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 818.440M--
--2023/Q1-- / 531.619M--
--2024/Q3843.877M / 765.760M--
--2024/Q2764.990M / 770.395M--
--2024/Q1735.775M / 700.292M--

Unlock Free Earnings Estimates

Betta Pharmaceuticals Earnings Reports

  • Betta Pharmaceuticals: Report for the third quarter of 2024

    Oct 28 12:00 ET

  • Betta Pharmaceuticals: Summary of Half-Year Report in 2024.

    Aug 5 12:00 ET

  • Betta Pharmaceuticals: Half-year report for the year 2024.

    Aug 5 12:00 ET

  • Betta Pharmaceuticals: 2024 Interim Performance Forecast

    Jul 23 12:00 ET

    • Read more

    Top CN Stock Gainers
    Symbol Price % Chg
    Zhejiang Lanyu Digital Technology
    301585
    73.00 +204.80%
    BBK Test Systems
    301598
    83.98 +118.36%
    MEIZHIGAO
    834765
    29.18 +29.98%
    Youkeshu Technology
    300209
    5.75 +20.04%
    Hangzhou Raycloud Technology Co.,Ltd
    688365
    13.90 +20.03%

    See the daily top gainer.

    Analysis

    Analyst Rating

    Updated: Dec 20, 2024

    Strong Buy

    • Strong Buy

      80.00%

    • Buy

      20.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Investment Theme Gene Sequencing
    Gene Sequencing
    Intraday+0.58%